Sun, 05th Jul 2020 07:33
LONDON, July 5 (Reuters) - Britain is close to agreeing a
500 million pound ($624 million) supply deal with Sanofi
and GlaxoSmithKline for 60 million doses of
their potential COVID-19 vaccine, the Sunday Times reported.
The newspaper said that Britain was considering taking an
option to buy the vaccine should it work in human trials, which
are due to begin in September.
($1 = 0.8011 pounds)
(Reporting by Alistair Smout;Editing by Elaine Hardcastle)
May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a...
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U....
FTSE 100 down 0.3%, FTSE 250 off 0.2% *
(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal...
Glaxosmithkline (GSK)